Omdia is part of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCb
Trialbee's Smart Patient Matching drives 30% referral conversion rate
A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients.
Offered Free by: Trialbee AB
See All Resources from: Trialbee AB